- Home
- MGEE vs OGN Comparison
MGEE vs OGN Comparison
Compare MGEE & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGEE
- OGN
- Stock Information
- Founded
- MGEE 1855
- OGN 1923
- Country
- MGEE United States
- OGN United States
- Employees
- MGEE N/A
- OGN N/A
- Industry
- MGEE Electric Utilities: Central
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- MGEE Energy
- OGN Health Care
- Exchange
- MGEE Nasdaq
- OGN Nasdaq
- Market Cap
- MGEE 3.1B
- OGN 2.5B
- IPO Year
- MGEE N/A
- OGN N/A
- Fundamental
- Price
- MGEE $87.74
- OGN $9.44
- Analyst Decision
- MGEE Sell
- OGN Hold
- Analyst Count
- MGEE 1
- OGN 4
- Target Price
- MGEE $74.00
- OGN $18.00
- AVG Volume (30 Days)
- MGEE 140.0K
- OGN 4.8M
- Earning Date
- MGEE 08-06-2025
- OGN 08-05-2025
- Dividend Yield
- MGEE 2.06%
- OGN 0.85%
- EPS Growth
- MGEE 12.86
- OGN N/A
- EPS
- MGEE 3.60
- OGN 2.69
- Revenue
- MGEE $701,317,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- MGEE $10.77
- OGN N/A
- Revenue Next Year
- MGEE $3.48
- OGN $1.02
- P/E Ratio
- MGEE $24.22
- OGN $3.51
- Revenue Growth
- MGEE 8.61
- OGN N/A
- 52 Week Low
- MGEE $82.21
- OGN $8.01
- 52 Week High
- MGEE $109.22
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- MGEE 59.37
- OGN 49.73
- Support Level
- MGEE $84.10
- OGN $9.15
- Resistance Level
- MGEE $86.17
- OGN $9.48
- Average True Range (ATR)
- MGEE 1.66
- OGN 0.45
- MACD
- MGEE 0.40
- OGN 0.03
- Stochastic Oscillator
- MGEE 96.63
- OGN 56.14
About MGEE MGE Energy Inc
MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings. MGE's generation mix is 40% coal, 21% renewable energy, 17% natural gas, and third-party purchased power.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.